Clinical Trials Browser

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Dermatomyositis, Lupus Erythematosus, Systemic, Multiple Sclerosis, Psoriasis, Scleroderma, Systemic, Sjogren's Syndrome, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Hematologic Neoplasms

NCT02972801 2026-04-22

Testicular Tissue Cryopreservation for Fertility Preservation

Phase NA Recruiting

1,500 enrolled

Autoimmune Diseases, Infertility, Neoplasms

NCT04452305 2026-04-22

Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting

Phase NA Recruiting

10 enrolled

Autoimmune Diseases, Infertility, Male, Neoplasms

NCT07470151 2026-03-13

Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases

Phase NA Recruiting

12 enrolled

Autoimmune Diseases, Lupus Erythematosus, Systemic, Myasthenia Gravis, Scleroderma, Diffuse

NCT01758042 2026-03-06

BMT

Phase NA Completed

10 enrolled

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Immunoglobulin Light-chain Amyloidosis, Anemia, Aplastic, Anemia, Sickle Cell, Autoimmune Diseases, Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Thalassemia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Anemia, Diamond-Blackfan, Renal Insufficiency, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

NCT00716066 2026-02-27

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

Phase 2 Active not recruiting

53 enrolled

CNS

Rasmussen subacute encephalitis, Autoimmune Diseases, Myasthenia Gravis, Neuromyelitis Optica, Lambert-Eaton Myasthenic Syndrome, Stiff-Person Syndrome, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Vasculitis, Central Nervous System, Opsoclonus-Myoclonus Syndrome

NCT06817889 2026-02-27

Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals

Phase 2 Recruiting

60 enrolled

Autoimmune Diseases, Respiratory Syncytial Virus Infections

NCT06626919 2026-02-25

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

Phase 1 Recruiting

30 enrolled

Autoimmune Diseases, Muscular Diseases, Myasthenia Gravis, Muscle Weakness, Autoimmune Diseases of the Nervous System, Neuromuscular Manifestations

NCT01351805 2025-12-03

VITAL

Phase NA Completed

25,871 enrolled 15 charts

Arthritis, Rheumatoid, Autoimmune Diseases, Osteoarthritis, Psoriasis

NCT05451212 2025-11-10

Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis

Phase 1 Completed

7 enrolled

Autoimmune Diseases, Immune System Diseases, Musculoskeletal Diseases, Myasthenia Gravis, Neuromuscular Diseases, Muscle Weakness

NCT07032129 2025-06-22

BAH2573

Phase 1/2 Recruiting

60 enrolled

Plasma cell

Autoimmune Diseases, Multiple Myeloma, Neoplasms, Plasma Cell

NCT05737160 2025-05-23

Study of Telitacicept in Generalized Myasthenia Gravis

Phase 3 Completed

114 enrolled

Autoimmune Diseases, Myasthenia Gravis, Muscle Weakness

NCT06827587 2025-02-14

Efficacy and Safety of Efgartigimod Sequential Therapy with Telitacicept in Generalized Myasthenia Gravis

Phase NA Not yet recruiting

60 enrolled

Autoimmune Diseases, Myasthenia Gravis, Neuromuscular Diseases

NCT06723548 2024-12-09

Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis

Phase 4 Not yet recruiting

30 enrolled

Autoimmune Diseases, Myasthenia Gravis

NCT04561557 2024-10-30

CARTinNS

Phase EARLY_PHASE1 Recruiting

36 enrolled

Plasma cell

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Autoimmune Diseases, Multiple Sclerosis, Myasthenia Gravis, Myositis, Neuromyelitis Optica, POEMS Syndrome, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

NCT05777499 2024-10-23

MUSICS

Phase NA Recruiting

75 enrolled

CNS

Brain Injuries, Traumatic, Autoimmune Diseases, Brain Injuries, Brain Neoplasms, Encephalitis, Meningitis, Peripheral Nervous System Diseases, Spinal Cord Injuries, Subarachnoid Hemorrhage, Trauma, Nervous System, Stroke

NCT06567080 2024-08-22

JWCAR201 for the Treatment of Hematology Malignancy and Autoimmune Diseases

Phase 1 Not yet recruiting

15 enrolled

Autoimmune Diseases, Lupus Erythematosus, Systemic

NCT01793519 2024-02-28

STARA

Phase 4 Unknown

290 enrolled

Arthritis, Rheumatoid, Autoimmune Diseases

NCT03283826 2024-02-23

EMBOLD

Phase 1/2 Terminated

134 enrolled

Autoimmune Diseases, Demyelinating Diseases, Inflammation, Multiple Sclerosis, Epstein-Barr Virus Infections, Multiple Sclerosis, Chronic Progressive

NCT06035614 2023-09-13

Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating Vitiligo on Children

Phase NA Completed

50 enrolled

LymphoidOther hematologic neoplasm

Autoimmune Diseases, Skin Diseases, Vitiligo, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03656627 2023-02-15

Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease

Phase 1 Terminated

7 enrolled

Thoracic

Arthritis, Rheumatoid, Autoimmune Diseases, Carcinoma, Non-Small-Cell Lung, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Multiple Sclerosis, Polymyalgia Rheumatica, Psoriasis, Giant Cell Arteritis

NCT04791150 2021-05-10

Rheumatologic Adverse Events and Cancer Immunotherapy

Phase NA Unknown

400 enrolled

Arthritis, Autoimmune Diseases, Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT02765594 2017-09-20

HCQIgAN

Phase 4 Unknown

98 enrolled

Genitourinary

Autoimmune Diseases, Glomerulonephritis, Glomerulonephritis, IGA, Immune System Diseases, Kidney Diseases, Nephritis, Urologic Diseases

NCT01545518 2014-09-01

IVIG Treatment for Refractory Immune-Related Adult Epilepsy

Phase 2 Terminated

20 enrolled 3 charts

Drug Resistant Epilepsy, Autoimmune Diseases, Epilepsy, Epilepsies, Partial, Autoimmune Diseases of the Nervous System, Limbic Encephalitis

NCT01210716 2013-09-23

Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device

Phase 3 Completed

37 enrolled 7 charts

Genitourinary

Autoimmune Diseases, Hematologic Diseases, Kidney Diseases, Nervous System Diseases, Paraproteinemias

NCT00817752 2010-03-18

Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation

Phase 1 Completed

25 enrolled

Autoimmune Diseases, Inflammation, Neoplasms

NCT00466843 2009-06-02

Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome

Phase 2 Unknown

54 enrolled

MyeloidOther hematologic neoplasm

Autoimmune Diseases, Leukemia, Myelodysplastic Syndromes

Clinical Trials

Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Testicular Tissue Cryopreservation for Fertility Preservation

Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting

Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases

BMT

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

VITAL

Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis

BAH2573

Study of Telitacicept in Generalized Myasthenia Gravis

Efficacy and Safety of Efgartigimod Sequential Therapy with Telitacicept in Generalized Myasthenia Gravis

Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis

CARTinNS

MUSICS

JWCAR201 for the Treatment of Hematology Malignancy and Autoimmune Diseases

STARA

EMBOLD

Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating Vitiligo on Children

Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease

Rheumatologic Adverse Events and Cancer Immunotherapy

HCQIgAN

IVIG Treatment for Refractory Immune-Related Adult Epilepsy

Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device

Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation

Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome